共查询到20条相似文献,搜索用时 0 毫秒
1.
Long‐term auditory complications after childhood cancer: A report from the Swiss Childhood Cancer Survivor Study 下载免费PDF全文
Annette Weiss Grit Sommer Rahel Kasteler Katrin Scheinemann Michael Grotzer Martin Kompis Claudia E. Kuehni for the Swiss Pediatric Oncology Group 《Pediatric blood & cancer》2017,64(2):364-373
2.
3.
4.
5.
6.
Camille Vercasson Pascal Auquier Grard Michel Yves Bertrand Sophie Ansoborlo Marie‐Dominique Tabone Guy Leverger Virginie Gandemer Andr Baruchel Audrey Contet Jean‐Hugues Dalle Catherine Paillard Maryline Poire Sandrine Thouvenin‐Doulet Nicolas Sirvent Justyna Kanold Claire Freycon Zeinab Hamidou Julie Berbis 《Pediatric blood & cancer》2020,67(10)
7.
8.
9.
10.
11.
Davies SM 《Pediatric blood & cancer》2007,48(7):727-730
Survival of children diagnosed with cancer has improved markedly, because of improvements in chemotherapy and radiation treatment protocols, better diagnosis, and risk classification and improved supportive care. Significant numbers of survivors are now entering their 30s and 40s, and data indicate that excess mortality continues in this group at least as long as 25 to 30 years after treatment. The Childhood Cancer Survivor Study (CCSS) is a large cohort study of 14,054 childhood cancer survivors who have been followed for over 13 years, with a median time from diagnosis now approaching 20 years. This cohort offers an extraordinary opportunity to study therapy-associated subsequent malignant neoplasms, and has allowed improved definition of incidence and risk factors for subsequent breast and thyroid cancer. The collection of genetic samples from members of the cohort has allowed the inclusion of studies of genetic susceptibility to subsequent malignant neoplasms in this population with a uniquely well-defined carcinogenic exposure. The planned formation of a new CCSS cohort, treated with more modern therapy, will allow the extension of these studies to younger populations and will define their experience of subsequent malignant neoplasms. 相似文献
12.
13.
14.
Tobacco Use Among Siblings of Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study 下载免费PDF全文
David Buchbinder MD MSHS Kevin Oeffinger MD Conrado Franco‐Villalobos BS MS Yutaka Yasui PhD Melissa A. Alderfer PhD Gregory T. Armstrong MD Jacqueline Casillas MD MSHS Jennifer Ford MD Kevin R. Krull PhD Wendy Leisenring PhD Christopher Recklitis PhD MPH Leslie L. Robison PhD Lonnie K. Zeltzer MD E. Anne Lown DrPH 《Pediatric blood & cancer》2016,63(2):326-333
15.
Leontien C.M. Kremer MD PhD Kevin C. Oeffinger MD Smita Bhatia MD MPH Wendy Landier RN PhD Gill Levitt MD Louis S. Constine MD W. Hamish Wallace MD Huib N. Caron MD PhD Saro H. Armenian MD MPH Roderick Skinner MB PhD Melissa M. Hudson MD 《Pediatric blood & cancer》2013,60(4):543-549
Childhood and young adult cancer survivors should receive optimum care to reduce the consequences of late effects and improve quality of life. We can facilitate achieving this goal by international collaboration in guideline development. In 2010, the International Late Effects of Childhood Cancer Guideline Harmonization Group was initiated. The aim of the harmonization endeavor is to establish a common vision and integrated strategy for the surveillance of late effects in childhood and young adult cancer survivors. With the implementation of our evidence‐based methods, we provide a framework for the harmonization of guidelines for the long‐term follow‐up of childhood and young adult cancer survivors. Pediatr Blood Cancer 2013; 60: 543–549. © 2012 Wiley Periodicals, Inc. 相似文献
16.
Michel G von der Weid NX Zwahlen M Redmond S Strippoli MP Kuehni CE;Swiss Paediatric Oncology Group 《Pediatric blood & cancer》2008,50(1):46-51
Background
This report describes the incidence of childhood cancer in Switzerland, based on the data from the Swiss Childhood Cancer Registry (SCCR), a national hospital‐based cancer registry with very high coverage, founded in 1976 by the Swiss Paediatric Oncology Group (SPOG).Procedure
Malignancies were coded according to the International Classification of Childhood Cancer (ICCC‐3). Incidence rates per 100,000 person‐years were calculated for all malignancies and groups of malignancies in Swiss residents less than 15 years of age for the decade 1995–2004.Results
The SCCR annually registered on average 174 new cases of cancer in Swiss residents aged <15 years, with a median age at diagnosis of 5.6 years. The crude incidence of childhood cancer in children aged <15 years was 13.5, higher for boys (15.0 per 100,000) than for girls (12.1 per 100,000), and was nearly twice as high in the first 5 years of life (19.3 per 100,000) than in the age group 5 to 14 years (10.8 per 100,000).Conclusion
Incidence of childhood cancers in the SCCR was similar to neighbouring countries and to data published by regional cancer registries in Switzerland for the same period, suggesting good completeness of registration. This makes the SCCR a valuable resource for national and international research on childhood cancer. Pediatr Blood Cancer 2008;50:46–51. © 2007 Wiley‐Liss, Inc. 相似文献17.
18.
19.